Cargando…
The potential of the inodilator levosimendan in maintaining quality of life in advanced heart failure
Maintaining adequate quality of life (QoL) is an important therapeutic objective for patients with advanced heart failure and, for some patients, may take precedence over prolonging life. Achieving good QoL in this context may involve aspects of patient care that lie outside the familiar limits of h...
Autores principales: | Nieminen, Markku S., Fonseca, Cândida, Brito, Dulce, Wikström, Gerhard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5932556/ https://www.ncbi.nlm.nih.gov/pubmed/29249906 http://dx.doi.org/10.1093/eurheartj/sux003 |
Ejemplares similares
-
The inodilator levosimendan in repetitive doses in the treatment of advanced heart failure
por: Delgado, Juan F., et al.
Publicado: (2017) -
The inodilator levosimendan as a treatment for acute heart failure in various settings
por: Gustafsson, Finn, et al.
Publicado: (2017) -
Pharmacological approaches to cardio-renal syndrome: a role for the inodilator levosimendan
por: Fedele, Francesco, et al.
Publicado: (2017) -
Inotropes and Inodilators for Acute Heart Failure: Sarcomere Active Drugs in Focus
por: Nagy, László, et al.
Publicado: (2014) -
Repetitive levosimendan treatment in the management of advanced heart failure
por: Oliva, Fabrizio, et al.
Publicado: (2018)